A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PROOF OF CONCEPT STUDY OF THE EFFICACY AND THE SAFETY OF GEVOKIZUMAB IN THE TREATMENT OF PATIENTS WITH GIANT CELL ARTERITIS

Registry ID

CL2-78989-012

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

SERVIER CANADA INC

Start date

2015-04-23

Last update

2014-02-28

Conditions

• GIANT CELL ARTERITIS

Related clinical trials

• A RANDOMIZED DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF ABATACEPT (CTLA4-IG IN GIANT CELL ARTERITIS (ABAGART))
• A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND,PROOF-OF-CONCEPT STUDY TO EVALUATE GUSELKUMAB FOR THE TREATMENT OF PARTICIPANTS WITH NEW-ONSET OR RELAPSING GIANT CELL ARTERITIS

View on source registry